Monitoring the response of cutaneous leishmaniasis patients to treatment with pentamidine isethionate by quantitative real-time polymerase chain reaction and identification of Leishmania parasites not responding to therapy.
- Authors
- D. Mans, A.D. Kent, R.V.P.F. Hu, E.J. Lai A Fat, G.J. Schoone, E.R. Adams, E. Rood, S. Alba, H.J.C. De Vries, L.O.A. Sabajo, R.F.M. Lai A Fat, H.D.F.H. Schallig
Leishmania (Viannia) guyanensis is believed to be the principal cause of cutaneous leishmaniasis (CL) in Suriname. This disease is treated with pentamidine isethionate (PI), but treatment failure has increasingly been reported.
